Firstsource Reports ₹140 Cr Q4 Profit, Slashes Debt After TeleMedik Deal

TECH
Whalesbook Corporate News Logo
AuthorVihaan Mehta|Published at:
Firstsource Reports ₹140 Cr Q4 Profit, Slashes Debt After TeleMedik Deal
Overview

Firstsource Solutions reported ₹140.03 Cr in standalone net profit for Q4 FY26 and ₹432.10 Cr for the full fiscal year. The company also slashed long-term borrowings to ₹189.67 Cr by March 31, 2026. This financial strengthening followed the January 2026 acquisition of TeleMedik, expanding its healthcare offerings.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

Firstsource Solutions Reports Strong FY26 Results, Boosts Financial Health

Firstsource Solutions announced its financial results for the fiscal year ending March 31, 2026. The company reported a standalone net profit of ₹140.03 Crores for the fourth quarter (Q4 FY26) and ₹432.10 Crores for the full fiscal year.

Key Financial Highlights

The company significantly improved its balance sheet during the fiscal year. Consolidated long-term borrowings were reduced from ₹341.90 Crores in March 2025 to ₹189.67 Crores by March 2026. Alongside this debt reduction, consolidated total equity saw an increase, growing from ₹4,098.03 Crores to ₹4,384.93 Crores over the same period. The statutory auditors issued an unqualified opinion on the financial statements, confirming their accuracy.

Strategic Acquisition Bolsters Healthcare Segment

A key move during the year was the 100% acquisition of TeleMedik, finalized in January 2026. This strategic step enhances Firstsource's capabilities in clinical care services and expands its presence within the US healthcare payer and provider markets.

Driving Shareholder Value

These results underscore Firstsource's commitment to financial discipline and strategic growth. The reduction in debt strengthens its financial foundation, while the TeleMedik acquisition positions the company for further expansion in the high-growth healthcare sector. This dual approach aims to build long-term shareholder value.

Company Growth and Market Position

Firstsource has been on a clear growth path, achieving an annualized revenue run-rate of US$1 billion in FY25 and consistently securing substantial new deals. Recent quarters have shown strong year-on-year revenue growth, with Q1 FY26 revenue up 23.8% and Q2 FY26 revenue up 20.2%, indicating sustained business momentum.

Operational Impact and Outlook

Shareholders can expect a deleveraged balance sheet. The TeleMedik acquisition is set to deepen Firstsource's reach in the healthcare business process management (BPM) and telehealth services market. The increased equity base provides greater financial stability and capacity for future investments. Investors will be watching the successful integration of TeleMedik and its contribution to revenue and profitability.

Competitive Landscape

Firstsource operates within the competitive business process management (BPM) and IT services sector. Its key competitors include WNS, Hinduja Global Solutions, and eClerx Services, all of which serve similar industry verticals like healthcare and banking, financial services, and insurance (BFSI).

Risks and Future Tracking

The company's filing did not identify specific financial risks related to the standalone profit and loss or consolidated balance sheet data. Going forward, investors will monitor the company's ability to maintain healthy EBIT margins and achieve its revenue growth targets for FY26. Continued deal wins, particularly in strategic sectors like healthcare, will be crucial for sustaining growth momentum. Updates on further balance sheet improvements or capital allocation strategies will also be closely tracked.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.